From: Becker's Supply Chain Report <>
Subject: Naloxone maker to offer cheaper generic after pricing scrutiny | Michael Dowling: What not to do as a leader | Olympus settles scope investigation for $85M | Shingles vaccine shortage worsens
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ View our videos on YouTube

December 12, 2018
1. Virginia naloxone maker to launch generic version, drop list price by $3,922 
2. Shingles vaccine shortage worsens  Full story

3. Michael Dowling: What not to do as a leader  Full story

4. Hospitals realize 15-25% savings for medical labels and wristbands through a free cross-reference and standardization program. Learn how

5. House passes drug-pricing bill targeting 'big pharma's games'

6. Glassdoor: 9 best hospitals to work for in 2019  Full story
7. Ergotron's documentation carts power life-changing care with safe battery technology. Most critically, they enable caregivers to focus on what's most important: patients. Learn more

8. 6 Michigan physicians charged in $464M billing fraud scheme  Full story
9. Amazon's healthcare hiring spree: 4 things to know  Full story
10. Probe of US generic drug 'cartel' grows to 16 companies, 47 states  Full story
11. Bridge the gap and assure true interoperability with an enterprise imaging solution. For a breakdown of key enterprise imaging considerations, click here.

12. Olympus settles federal scope investigation for $85M

Contact Us

Editorial Contact: 
Molly Gamble 
(800) 417-2035
Sales, Marketing & Events:
Jessica Cole
President and CEO
Becker's Hospital Review
A Becker's Healthcare Publication
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601
Becker's Healthcare, 35 E. Wacker, Suite 1782, Chicago, IL 60601
Sent by in collaboration with
Constant Contact